EUVIMEDEUVIMED entdecken
Crossref

Exploring pharmacological treatment for trichotillomania: do we need better education?

Piotr K Krajewski iD, Henner Zirpel, David Saceda-Corralo iD, Diamant Thaçi, Jacek C Szepietowski iD

International Journal of Dermatology · 2025-01 · 64 (1) · 92-100

DOI: 10.1111/ijd.17269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dermatology, online erschienen am 26.05.2024. Verfasst von Piotr K Krajewski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland. Hauptthemen laut MEDLINE: Trichotillomania, Antipsychotic Agents, Practice Patterns, Physicians', Benzodiazepines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Excellence Cluster Precision Medicine in Chronic Inflammation, Schleswig-Holstein Excellence-Chair Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Trichotillomania, also known as hair‐pulling disorder, is a chronic psychiatric condition with a fluctuating course in which an individual pulls out their hair, leading to visible hair loss and psychosocial sequelae. Due to the unknown pathogenesis, the treatment of this disorder is complex and remains a challenge for dermatologists and psychiatrists. Since guidelines for treating trichotillomania are lacking and, consequently, no common treatment strategy exists, we decided to perform a large‐scale, global retrospective cohort study to assess the characterized real‐world prescription patterns in treating trichotillomania.

Methods

The research used the TrinetX database for patients with trichotillomania (ICD 10 – F63.3) within the European and the United States Collaborative Network (EC and UC, respectively). After consulting with a psychodermatology expert, a list of 25 medications was investigated.

Results

Data on the prescription drugs of 1,275 patients from the EC and 109,741 patients from the UC were collected. In both the EC and UC cohorts, benzodiazepine derivatives, particularly lorazepam and midazolam, were the most commonly prescribed sedatives/hypnotics. Antipsychotic prescriptions, primarily haloperidol, followed benzodiazepines. After the trichotillomania diagnosis, notable changes in drug prescriptions for the EC cohort, including an increased likelihood of receiving acetylcysteine, haloperidol, quetiapine, sertraline, olanzapine, and risperidone were observed. The UC cohort showed minimal changes. Overall, both cohorts leaned toward benzodiazepine prescriptions (37% UC, 21% EC) and had limited antidepressant usage. Haloperidol (19.3%) and quetiapine (15.1%) were commonly prescribed in both cohorts.

Conclusions

The results of our study indicate that the real‐world prescription patterns for trichotillomania differ significantly from the expert‐proposed therapeutic approach and point toward the necessity of creating standards of pharmacological care and better education.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrichotillomaniaAntipsychotic AgentsPractice Patterns, Physicians'BenzodiazepinesHumansRetrospective StudiesFemaleAdultMaleYoung AdultMiddle AgedUnited StatesAntidepressive AgentsDrug PrescriptionsAdolescentSertralineEurope

Stichwörter der Autor:innen

TriNetXacetylcysteinehair disordersobsessive‐compulsive disordertreatmenttrichotillomania

Substanzen

Antipsychotic AgentsBenzodiazepinesAntidepressive AgentsSertraline

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
  • Comprehensive Center for Inflammation Medicine, University-Hospital Schleswig-Holstein, Lübeck, Germany.
  • Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Departamento de Medicina, Facultad de Medicina, Universidad de Alcalá, Madrid, Spain.
  • Trichology Unit, Grupo de Dermatología Pedro Jaén, Madrid, Spain.

ORCID-Profile: Piotr K Krajewski, David Saceda-Corralo, Jacek C Szepietowski

Förderung

  • Excellence Cluster Precision Medicine in Chronic Inflammation
  • Schleswig-Holstein Excellence-Chair Program

Zitieren

APA

Krajewski, P. K., Zirpel, H., Saceda-Corralo, D., Thaçi, D., & Szepietowski, J. C. (2025). Exploring pharmacological treatment for trichotillomania: do we need better education?. International Journal of Dermatology, 64(1), 92-100. https://doi.org/10.1111/ijd.17269

Vancouver

Krajewski PK, Zirpel H, Saceda-Corralo D, Thaçi D, Szepietowski JC. Exploring pharmacological treatment for trichotillomania: do we need better education?. International Journal of Dermatology. 2025;64(1):92-100. doi:10.1111/ijd.17269

BibTeX
@article{Krajewski2025,
  author = {Krajewski, Piotr K and Zirpel, Henner and Saceda-Corralo, David and Thaçi, Diamant and Szepietowski, Jacek C},
  title = {Exploring pharmacological treatment for trichotillomania: do we need better education?},
  journal = {International Journal of Dermatology},
  year = {2025},
  volume = {64},
  number = {1},
  pages = {92--100},
  doi = {10.1111/ijd.17269}
}
Kostenlos starten →